IntraSight Interventional applications platform

IntraSight

Interventional applications platform

Find similar products

The IntraSight applications platform is where imaging, physiology, co-registration* and software all come together to clearly identify coronary and peripheral artery disease, and allow for more optimized treatment plans. IntraSight is built on a new foundational platform designed to meet the evolving needs of your lab today and tomorrow.

  • 1. Davies JE, et al., Use of the Instantaneous Wave-free Ration or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.
  • 2. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
  • 3. Witzen B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470.
  • *Co-registration tools available within IntraSight 7 configuration via SyncVision
BannerImage

Let us know how we can help

We are always interested in engaging with you

1
Select your area of interest
2
Contact details
1
2
Contact details

Submit a sales inquiry

Please provide some information below and we can help direct you to the right person.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*
*
*
*
*
*
*
*
*
BannerImage

Let us know how we can help

We are always interested in engaging with you

1
Select your area of interest
2
Contact details
1
2
Contact details

Submit a sales inquiry

Please provide some information below and we can help direct you to the right person.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*
*
*
*
*
*
*
*
*